Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Alena Klochkova"'
Autor:
Charline Ogier, Alena Klochkova, Linara Gabitova-Cornell, Battuya Bayarmagnai, Diana Restifo, Aizhan Surumbayeva, Debora Barbosa Vendramini-Costa, Ralph Francescone, Janusz Franco-Barraza, Jaye Gardiner, Emmanuelle Nicolas, Andrei Efimov, Elizabeth A. Handorf, Kathy Q. Cai, Bojana Gligorijevic, Edna Cukierman, Igor Astsaturov
Publikováno v:
Cancer Research. 82:C047-C047
Pancreatic ductal adenocarcinoma (PDAC) cells derive their resistance to therapy and aggressive clinical course from the symbiotic signaling and metabolic interactions with cancer-associated fibroblasts (CAFs). Trogocytosis is a process of “nibblin
Autor:
Charline Ogier, Alena Klochkova, Battuya Bayarmagnai, Linara Gabitova, Diana Restifo, Aizhan Surumbayeva, Janusz Franco-Barraza, Debora Vendramini Costa, Ralph Francescone, Jaye Gardiner, Emmanuelle Nicolas, Elizabeth A. Handorf, Kathy Q. Cai, Edna Cukierman, Igor Astsaturov
Publikováno v:
Cancer Research. 82:1571-1571
Pancreatic ductal adenocarcinoma (PDAC) cells derive their resistance to therapy and aggressive clinical course from the symbiotic signaling and metabolic interactions with cancer-associated fibroblasts (CAFs). CAFs have been shown to provide nutrien
Autor:
Charline Ogier, Elizabeth Handorf, Jaye C. Gardiner, Diana Restifo, Ralph Francescone, Janusz Franco-Barraza, Linara Gabitova, Emmanuelle Nicolas, Kathy Q. Cai, Battuya Bayarmagnai, Alena Klochkova, Aizhan Surumbayeva, Igor Astsaturov, Débora Barbosa Vendramini-Costa, Edna Cukierman
Publikováno v:
Cancer Research. 81:PR-015
Pancreatic ductal adenocarcinoma (PDAC) cells derive their resistance to therapy and aggressive clinical course from the symbiotic signaling and metabolic interactions with cancer-associated fibroblasts (CAFs). CAFs have been shown to provide to meta
Autor:
Edna Cukierman, Diana Restifo, Alena Klochkova, Linara Gabitova, Igor Astsaturov, Tiffiney R. Hartman, Aleksandra M. Mazitova
Publikováno v:
Cancer Research. 77:438-438
Pancreatic cancer is rapidly rising to become the 2nd leading cause of cancer deaths by 2020 in the USA. The rise in pancreatic cancer incidence is paralleled by the epidemic of obesity, type 2 diabetes, and associated increase in blood cholesterol,